20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
American Healthcare REIT, Inc. (AHR) operates in the REIT - HEALTHCARE FACILITIES industry and is headquartered in Irvine, United States with about 121 employees. Its market capitalization is roughly $11 billion. In the fiscal year ended 2025-12-31, AHR reported $2.3B in revenue and $70M in net income.
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man.
Interactive charts & full statements → Open the AHR valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $2.5B | $2.3B | $2.1B | $1.9B | $1.6B | $1.3B | $1.2B | $1.2B | $1.1B | $1.0B | $980M |
| Gross Profit | — | $40M | $417M | $357M | $336M | $182M | $159M | $219M | $208M | $212M | $180M |
| Gross Margin % | — | 1.8% | 20.1% | 19.2% | 20.8% | 14.4% | 13.4% | 18.0% | 18.4% | 20.2% | 18.4% |
| Operating Income (EBIT) | $169M | $168M | $137M | $77M | $91M | $139M | $132M | $190M | $179M | $179M | $152M |
| Operating Margin % | 6.8% | 7.4% | 6.6% | 4.1% | 5.6% | 11.0% | 11.1% | 15.5% | 15.8% | 17.1% | 15.5% |
| Net Income | $122M | $70M | ($38M) | ($71M) | ($81M) | ($48M) | $2M | ($5M) | $13M | $11M | ($146M) |
| Net Margin % | 4.9% | 3.1% | -1.8% | -3.8% | -5.0% | -3.8% | 0.2% | -0.4% | 1.2% | 1.1% | -14.9% |
| EBITDA | — | $322M | $315M | $324M | $234M | $159M | $165M | $218M | $179M | $179M | $152M |
| Earnings Per Share (EPS) | $0.69 | $0.42 | $-0.29 | $-1.08 | $-1.23 | $-0.72 | $0.03 | $-0.11 | $0.27 | $0.23 | $-3.01 |
| Shares Outstanding (M) | — | 167M | 131M | 66M | 66M | 66M | 66M | 45M | 50M | 50M | 49M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $674M | $651M | $604M | $573M | $543M | $541M | $543M | $524M | $505M |
| Gross Profit | — | ($9M) | $1M | $118M | $116M | $108M | $112M | $107M | $102M |
| Gross Margin % | — | -1.3% | 0.1% | 20.7% | 21.4% | 20.0% | 20.7% | 20.4% | 20.2% |
| Operating Income (EBIT) | $45M | $42M | $40M | $42M | $46M | $40M | $40M | $37M | $32M |
| Operating Margin % | 6.7% | 6.5% | 6.6% | 7.4% | 8.5% | 7.4% | 7.4% | 7.1% | 6.3% |
| Net Income | $31M | $24M | $11M | $56M | $10M | ($7M) | ($32M) | ($4M) | $2M |
| Net Margin % | 4.6% | 3.6% | 1.8% | 9.8% | 1.8% | -1.3% | -5.9% | -0.8% | 0.4% |
| EBITDA | — | $109M | $84M | $85M | $85M | $68M | $55M | $81M | $90M |
| Earnings Per Share (EPS) | $0.16 | $0.13 | $0.06 | $0.34 | $0.06 | $-0.04 | $-0.21 | $-0.03 | $0.02 |
| Shares Outstanding (M) | — | 188M | 167M | 163M | 161M | 157M | 154M | 134M | 131M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $369M | $294M | $176M | $99M | $148M | $18M | $219M | $117M | $107M | $128M | $114M |
| Capital Expenditures (CapEx) | $203M | $129M | $92M | $100M | $72M | $80M | $128M | $93M | $67M | $44M | $46M |
| Free Cash Flow (FCF) | $166M | $166M | $84M | ($1M) | $76M | ($62M) | $91M | $25M | $40M | $85M | $68M |
| FCF Margin % | 6.6% | 7.3% | 4.1% | -0.1% | 4.7% | -4.9% | 7.7% | 2.0% | 3.5% | 8.1% | 7.0% |
| Dividends Paid | — | $164M | $121M | $76M | $51M | $23M | $27M | $63M | $60M | $56M | $52M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $119M | $88M | $55M | $107M | $71M | $61M | $60M | $63M | $59M |
| Capital Expenditures (CapEx) | $48M | $38M | $69M | $48M | $27M | $21M | $30M | $24M | $18M |
| Free Cash Flow (FCF) | $71M | $50M | ($14M) | $59M | $45M | $39M | $30M | $39M | $41M |
| FCF Margin % | 10.5% | 7.6% | -2.3% | 10.3% | 8.2% | 7.3% | 5.5% | 7.5% | 8.1% |
| Dividends Paid | — | $47M | $43M | $41M | $40M | $40M | $38M | $33M | $33M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $5.7B | $5.4B | $4.5B | $4.6B | $4.8B | $4.6B | $3.2B | $3.2B | $2.9B | $2.8B | $2.8B |
| Cash & Cash Equivalents | $157M | $115M | $77M | $43M | $65M | $82M | $113M | $53M | $35M | $34M | $29M |
| Total Liabilities | $2.0B | $2.1B | $2.2B | $3.1B | $3.1B | $2.8B | $2.2B | $2.1B | $1.6B | $1.4B | $1.3B |
| Total Debt (Short + Long-Term) | — | $1.6B | $1.7B | $2.8B | $1.6B | $2.1B | $1.7B | $8M | $3M | $95M | $38M |
| Total Shareholders' Equity | $3.7B | $3.3B | $2.3B | $1.3B | $1.4B | $1.6B | $866M | $901M | $1.1B | $1.2B | $1.3B |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AHR viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms